Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-18

Clinical Trial Update: Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing an investigational yellow fever vaccine with YF-VAX in U.S. adults has posted results, and the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational Yellow Fever Vaccine (Phase 2 candidate)
  • YF-VAX (Yellow fever vaccine live)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Yellow Fever, Healthy Volunteers | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-18